Silo Pharma Inc SILO

Healthcare Psychedelics

Silo Pharma Inc. operates as a developmental stage biopharmaceutical company. The company is developing therapeutics that address underserved conditions, including post-traumatic stress disorder (PTSD), stress-induced anxiety disorders, fibromyalgia, and central nervous system (CNS) diseases. It focuses on developing traditional therapies and psychedelic treatments in formulations. The company’s lead program, SPC-15, is an intranasal treatment targeting PTSD and stress-induced anxiety disorders. In addition, the company is developing SP-26, a time-release ketamine-loaded implant for fibromyalgia and chronic pain relief. In addition, the company’s two preclinical programs comprise SPC-14, an intranasal compound for the treatment of Alzheimer’s disease, and SPU-16, a CNS-homing peptide targeting multiple sclerosis (MS). The company’s research and development programs are conducted through collaborations with Columbia University, Medspray Pharma BV, and the University of Maryland, Balt...

NDAQ:SILO - Post by User

Silo Pharma Inc

<< Previous

Bullboard Posts

Next >>

(1513)
•••

Post by Iseneschalon Jul 16, 2024 11:51am

57 Views

Post# 36134814

SILO....in PB mode after galliant effort

I say SILO will be doing a Green to red move shortly.....has to hold the L.O.D....currently tapping Intra-day RBL trend line...has to hold $2.07 or the next support is the L.O.D

<< Previous

Bullboard Posts

Next >>

Contractor killed in animal attack at Zoo Bay uranium mine